TOP2B and neuroblastoma: Remarkably, we found that CX-5461 was between 2- and 4-fold more effective at inhibiting TOP2B, compared to TOP2A (P = 2.8 × 10−4, Fig. 4L), confirming the broader relevance of this mechanism outside neuroblastoma cells.